Phase II study of dovitinib in first line metastatic or (nonresectable primary) adrenocortical carcinoma (ACC): SOGUG study 2011-03

被引：1
|
作者：
Garcia-Donas, Jesus
Hernando Polo, Susana
Guix, Marta
Climent Duran, Miguel Angel
Mendez Vidal, Maria Jose
Jimenez, Paula
Leon Mateos, Luis
Francisco Rodriguez-Moreno, Juan
Moreno, Fernando
Segura, Eduardo
Duran, Ignacio
Macia, Sonia
Arranz Arija, Jose Angel
Vazquez-Estevez, Sergio
Javier Perez, Francisco
Lainez, Nuria
Castellano, Daniel E.
机构：
[1] Ctr Integral Oncol Clara Campal, Madrid, Spain
[2] Hosp Univ Fdn Alcorcon, Alcorcon, Spain
[3] Univ Hosp Mar IMIM, Barcelona, Spain
[4] Fdn Inst Valenciano Oncol, Valencia, Spain
[5] Hosp Reina Sofia, Cordoba, Spain
[6] Hosp Univ Cent Asturias, Oviedo, Spain
[7] Complejo Hosp Univ Santiago, Oncol Serv, Santiago, Spain
[8] Hosp Clin Univ San Carlos, Madrid, Spain
[9] Novartis, Madrid, Spain
[10] Hosp Univ Virgen del Rocio, Seville, Spain
[11] Hosp Gen Elda, Elda, Spain
[12] Hosp Gen Gregorio Maranon, Madrid, Spain
[13] Hosp Univ Lucus Augusti, Lugo, Spain
[14] Inst Catala Oncol, Clin Res Unit, Lhospitalet De Llobregat, Spain
[15] Complejo Hosp Navarra, Pamplona, Spain
[16] Hosp Univ 12 Octubre, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4587
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Treatment with docetaxel and cisplatin in advanced adrenocortical carcinoma, a phase II study
    Urup, T.
    Pawlak, W. Z.
    Petersen, P. M.
    Pappot, H.
    Rorth, M.
    Daugaard, G.
    BRITISH JOURNAL OF CANCER, 2013, 108 (10) : 1994 - 1997
  • [42] Treatment with docetaxel and cisplatin in advanced adrenocortical carcinoma, a phase II study
    T Urup
    W Z Pawlak
    P M Petersen
    H Pappot
    M Rørth
    G Daugaard
    British Journal of Cancer, 2013, 108 : 1994 - 1997
  • [43] Phase II Study of S-1 plus Cisplatin as First-Line Therapy in Patients with Metastatic Esophageal Carcinoma
    Sun, Si
    Yu, Hui
    Wang, Huijie
    Zhang, Hai
    Wu, Xianghua
    Wang, Jialei
    Chang, Jianhua
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (03) : 115 - 122
  • [44] Gemcitabine plus docetaxel as first-line biweekly therapy in locally advanced and/or metastatic urothelial carcinoma: a phase II study
    Neri, Bruno
    Vannini, Laura
    Giordano, Clara
    Grifoni, Raffaella
    Pantaleo, Pietro
    Baldazzi, Valentina
    Crisci, Alfonso
    Lapini, Alberto
    Raugei, Andrea
    Carini, Marco
    ANTI-CANCER DRUGS, 2007, 18 (10) : 1207 - 1211
  • [45] Combination of docetaxel, cisplatin, and capecitabine (DCX) as a first-line chemotherapy in patients with metastatic gastric carcinoma: A phase II study
    Narimanov, Mekhty
    Tryakin, Alexey
    Bazin, Igor
    Kanagavel, Dheepak
    Tjulandin, Sergei
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [46] Phase I study of IV vinorelbine and capecitabine as first line treatment in metastatic breast carcinoma
    Favier, Laure
    Mayer, Francoise
    Chauffert, Bruno
    Zanetta, Sylvie
    de Gislain, Catherine
    Fumoleau, Pierre
    Fargeot, Pierre
    Garnier, Jerome
    Biville, Fabienne
    Coudert, Bruno
    ANNALS OF ONCOLOGY, 2004, 15 : 52 - 53
  • [47] First-line gemcitabine and carboplatin in advanced ovarian carcinoma: a phase II study
    Tay, S. K.
    Ilanchadran, A.
    Tan, T. Y.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2006, 113 (12) : 1388 - 1392
  • [48] Phase II study of weekly epirubicin and docetaxel as first line chemotherapy in metastatic breast cancer
    Gamucci, Teresa
    D'Ottavio, Anna Maria
    Gareri, Roberta
    Vaccaro, Angela
    Belli, Franca
    Nunziata, Corrado
    Meliffi, Loretta
    Moscetti, Luca
    Barduagni, Mario
    Sperduti, Isabella
    ANNALS OF ONCOLOGY, 2004, 15 : 48 - 49
  • [49] Phase II study of Taxotere in advanced or/and metastatic breast cancer as a first or second line of treatment
    Borisova, TA
    Orel, NF
    Pirogova, NA
    Gorbounova, VA
    ANNALS OF ONCOLOGY, 1998, 9 : 28 - 28
  • [50] Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma
    Berruti, Alfredo
    Sperone, Paola
    Ferrero, Anna
    Germano, Antonina
    Ardito, Arianna
    Priola, Adriano Massimiliano
    De Francia, Silvia
    Volante, Marco
    Daffara, Fulvia
    Generali, Daniele
    Leboulleux, Sophie
    Perotti, Paola
    Baudin, Eric
    Papotti, Mauro
    Terzolo, Massimo
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 166 (03) : 451 - 458
12345